These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 29852493)

  • 1. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
    Campbell KN; Tumlin JA
    Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.
    Alachkar N; Wei C; Arend LJ; Jackson AM; Racusen LC; Fornoni A; Burke G; Rabb H; Kakkad K; Reiser J; Estrella MM
    Transplantation; 2013 Oct; 96(7):649-56. PubMed ID: 23842190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
    Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
    Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
    Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
    Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
    J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
    Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
    Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
    Schwartz MM
    Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal Segmental Glomerulosclerosis.
    Rosenberg AZ; Kopp JB
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):502-517. PubMed ID: 28242845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiology of focal segmental glomerulosclerosis: new developments.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
    Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
    J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal segmental glomerulosclerosis; why does it occur segmentally?
    Nagata M; Kobayashi N; Hara S
    Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.